A synthetic PGE2 analog that has an inhibitory effect on gastric acid secretion, a mucoprotective effect, and a postprandial lowering effect on gastrin. It has been shown to be efficient and safe in the treatment of gastroduodenal ulcers.
Enprostil has been studied across 13 research domains including 🔬 Inflammation, 🦠 Gut & Microbiome, 🧠 Focus & Attention, 🔥 Metabolic, 🫁 Liver & Detox. The primary research focus is 🔬 Inflammation with 79% of studies addressing this area.
This evidence profile for Enprostil is generated deterministically from 174 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.